Michael A. Bookman, MD, is a faculty physicains with the University of Arizona College of Medicne – Tucson. He graduated from the Massachusetts Institute of Technology and Harvard Medical School, followed by residency training at Beth Israel Hospital in Boston. In 1988, after completing a senior staff fellowship within the Medicine Branch of the National Cancer Institute, he joined the Department of Medical Oncology at Fox Chase Cancer Center in Philadelphia, where he remained for 21 years, most recently as vice president for ambulatory care and clinical research. In September 2009, Dr. Bookman joined the UA Cancer Center in Tucson as professor of medicine and chief of the Division of Hematology-Oncology in the UA Department of MEdicine. In October 2014, he left those positions to join US Oncology Research (McKesson Specialty Health) as director for gynecologic oncology research, and became a staff physician with Arizona Oncology in Tucson to pursue private practice in gynecologic oncology.

For more than 20 years, he has worked closely with the Gynecologic Oncology Group (GOG) to support clinical research for women with gynecologic cancers, and mentorship for junior investigators. His roles have included chair of the Developmental Therapeutics Committee and the Committee on Information Technology. He has served as chair of the Ovarian Committee since August 2010, including its transition to NRG Oncology as part of the NCI National Clinical Trials Network. In addition, he served as principal investigator for GOG0182-ICON5, an international collaborative phase III trial for women with advanced ovarian cancer, which enrolled over 4,000 patients to evaluate new chemotherapy treatment combinations.

In July 2006, Dr. Bookman was appointed director of the Office of Educational Resources at the International Gynecologic Cancer Society (IGCS), continuing through 2016. This offered a unique opportunity to focus on the development of resources to support global and regional educational initiatives of the Society, targeting healthcare providers and patients in diverse international settings.

Within the National Comprehensive Cancer Network (NCCN), Dr. Bookman served as a member of the Outcomes Committee, and was a co-investigator for the breast cancer and ovarian cancer outcomes database projects, as well as a member of the Guidelines Committee for cancer of the uterus and cervix.

My primary goal is to make certain that you are supported by an integrated multidisciplinary team with specialized expertise in the care of women with gynecologic cancer, including surgery, chemotherapy, radiation therapy, nursing, genetics, supportive care, and the latest clinical research. I have more than 30 years experience with national and international clinical research organizations, and it is my personal mission to help bring the most promising emerging treatments to our patients. I also believe in individualized care, balancing the options for each patient, based on their general health, tumor biology, and personal preferences. Finally, I have a strong commitment to support educational programs in the developing world, and mentorship of junior investigators and clinicians at home.